NHS National Framework for Golimumab Injection

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework ()
Duration
not specified
Value
£60M
Sector
MISCELLANEOUS
Published
01 Sep 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

Geochart for 1 buyers and 3 suppliers

1 buyer

3 suppliers

Description

NHS National Framework for Golimumab Injection commencing 1st November 2025 Offer reference number: CM/TNS/25/5724 Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Award Detail

1 Janssen Cilag (High Wycombe)
  • NHS National Framework for Golimumab Injection commencing 1st November 2025
  • Reference: 1
  • Value: £60,000,000 [share]
  • Awarded to group of suppliers.
2 Mercury Pharmaceuticals (London)
  • NHS National Framework for Golimumab Injection commencing 1st November 2025
  • Reference: 1
  • Value: £60,000,000 [share]
  • Awarded to group of suppliers.
3 Orifarm (Hemel Hempstead)
  • NHS National Framework for Golimumab Injection commencing 1st November 2025
  • Reference: 1
  • Value: £60,000,000 [share]
  • Awarded to group of suppliers.

CPV Codes

  • None found

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains